Clinical Trial Detail

NCT ID NCT01262027
Title TKI258 for Metastatic Inflammatory Breast Cancer Patients
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements yes
Sponsors M.D. Anderson Cancer Center|Novartis
Indications

Her2-receptor negative breast cancer

breast cancer

Therapies

Dovitinib

Age Groups: adult

Additional content available in CKB BOOST